TRIATEC

This brand name is authorized in Brazil, Cyprus, France, Italy, Tunisia

Active ingredients

The drug TRIATEC contains one active pharmaceutical ingredient (API):

1 Ramipril UNII L35JN3I7SJ - RAMIPRIL

Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidylcarboxypeptidase I (synonyms: angiotensin-converting enzyme; kininase II). In plasma and tissue this enzyme catalyses the conversion of angiotensin I to the active vasoconstrictor substance angiotensin II, as well as the breakdown of the active vasodilator bradykinin. Reduced angiotensin II formation and inhibition of bradykinin breakdown lead to vasodilatation. Read about Ramipril

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09AA05	Ramipril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502814070066603, 502814070066703
Country: FR	Base de données publique des médicaments	Identifier(s): 60161143, 62095667, 62341282, 63524315, 64864071, 64987864, 67103203, 69279730, 69645380
Country: IT	Agenzia del Farmaco	Identifier(s): 027161052, 027161064, 027161076, 037956036, 038489047, 042732040, 043315035, 043315047, 043961010
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9263291, 9263292, 9263293